Search Results

<< Back to podcast list Strategic Partner(s) Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D. small molecules for their pre-clinical efficacy and to support the design of novel therapeutics. " Yao Lu (Jackie) on the web Monash University Georgina Sweet Fellowship Authorea Dr.

During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash Cam Sinh Lu on the web LinkedIn Dr.

Lukas Grätz About Dr. Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's Lukas Grätz on the web Karolinska Institutet ResearchGate PubMed Dr.

Matsunami's RTP1S chaperone, the Rho tag, and the Pluznick lab's Lucy tag — a cleavable leucine-rich kidney 19:56 The orthology problem: 1,000 mouse ORs, 350 human ones 23:08 RTP1S, the Rho tag, and the Lucy

Alexander Hauser , and Luise Wagner .

The lung's beta-2 story has been sitting in plain sight for fifty years.

development. have been engaged in GPCR cellular and clinical pharmacology as scientist or PI in neonatal lupus

Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr. Lee Limbird (1973) Dr.

From Curiosity to Collaboration “We decided to evaluate the multiplexing methods... and found this Luminex assay.” – Tom Sakmar After exploring several screening techniques, the lab adopted the Luminex bead-based

hear about peptide-binding GPCRs with buried or hydrophobic binding pockets, I immediately think: good luck

In 2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck

Annette Gilchrist About this episode Originally, Annette wanted to be a medical doctor but as luck has

Druey at NIAID/NIH, where I characterized the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fascinated by the multitude of processes that are regulated/dysregulated by GPCRs and RGS proteins in the lungs

project, licensed to AstraZeneca (Saphnelo™ Anifrolumab) that has just received FDA approval for systemic lupus

p38 signaling responses we are studying how atypical p38 controls the onset and pathogenesis of acute lung

David Hodson Topics Covered: LUXendin probes for GLP-1R labeling across imaging modalities daLUXendin

receptors 06:30 When the field debated whether opioid receptors were even proteins 11:31 The "dumb luck

LUXendin Family Red and far-red fluorescent GLP-1R antagonists derived from Exendin4(9–39). He is a principal architect of the LUXendin and daLUXendin probe families. Dr.

examine the assay principle, validation strategy, and performance across reference antagonists and agonis Lucía degenerative, metabolic, immunological… around a third of the drugs in clinical use are GPCR ligands Lucía

Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for

Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Stefan Diethelm , Luboš